Sassard J, Zech P Y, Pozet N, Cuisinaud G, Vincent M
J Pharmacol. 1983;14 Suppl 2:121-9.
The effects of a single oral dose and of an 8 week treatment with labetalol--an alpha 1- and beta 1-2-adrenoceptor blocking agent--and with atenolol--a beta 1-adrenoceptor blocking agent--were compared in 52 hypertensives. A single oral dose of atenolol induced a marked bradycardia without decrease in blood pressure. On the contrary labetalol lowered blood pressure but not resting heart rate. After an 8 week treatment both drugs exhibited a similar antihypertensive effect. However labetalol did not decrease heart rate and plasma renin activity as markedly as atenolol did. It was concluded that the alpha 1 blocking properties of labetalol were of importance in the development of the antihypertensive properties that this drug exhibits after a single or multiple administrations.
在52名高血压患者中比较了单次口服剂量以及使用拉贝洛尔(一种α1和β1 - 2肾上腺素能受体阻滞剂)和阿替洛尔(一种β1肾上腺素能受体阻滞剂)进行8周治疗的效果。单次口服阿替洛尔可引起明显的心动过缓,但血压未降低。相反,拉贝洛尔可降低血压,但静息心率未降低。经过8周治疗后,两种药物均表现出相似的降压效果。然而,拉贝洛尔降低心率和血浆肾素活性的程度不如阿替洛尔明显。得出的结论是,拉贝洛尔的α1阻断特性在该药物单次或多次给药后所表现出的降压特性的发展中具有重要意义。